GSK

NYSE: GSK · Real-Time Price · USD
38.98
0.18 (0.46%)
At close: Aug 15, 2025, 12:46 PM

GSK Income Statement

Financials in GBP. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
31.38B 30.33B 29.32B 34.11B
Cost of Revenue
9.05B 8.56B 9.55B 11.6B
Gross Profit
22.33B 21.76B 19.77B 22.51B
Operating Income
4.02B 6.75B 6.43B 6.2B
Interest Income
60M 40M 76M 28M
Pretax Income
3.48B 6.06B 5.63B 5.44B
Net Income
2.58B 4.93B 4.92B 4.38B
Selling & General & Admin
11.02B 9.38B 8.37B 10.97B
Research & Development
6.4B 6.22B 5.49B 5.28B
Other Expenses
891M -590M -523M 57M
Operating Expenses
18.31B 15.02B 13.34B 16.31B
Interest Expense
640M 775M 879M 784M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
27.36B 23.58B 22.89B 27.91B
Income Tax Expense
526M 756M 707M 346M
Shares Outstanding (Basic)
2.04B 2.03B 2.01B 1.6B
Shares Outstanding (Diluted)
2.07B 2.06B 2.04B 1.62B
EPS (Basic)
1.26 2.44 2.44 2.74
EPS (Diluted)
1.24 2.40 2.40 2.70
EBITDA
6.67B 9.14B 8.63B 7.76B
EBIT
4.12B 6.79B 6.45B 4.36B
Depreciation & Amortization
2.55B 2.29B 2.15B 2.12B